Author: admin
Advisory for Indian students
Advisory for Indian Students
(As on 1st June, 2025)
- Indian students desirous of studying medicine in Uzbekistan, if at all decide to engage an Education Consultant (EC), are advised that they avail services of only those ECs whose businesses are registered in India.
- Before the signing of the contract with EC, students and their guardians should seek EC’s Corporate Identification Number (CIN), Tax Deduction & Collection Account Number (TAN), and Permanent Account Number (PAN).
- ECs should be asked to provide their address and contact details both in India and Uzbekistan.
- Students are also advised to go through their websites and social media handles.
- As this Embassy has been receiving some complaints relating to fraud, non-payment of fee by some of the ECs to the university and non fulfilment of contractual obligations, it is reiterated that the contract agreement signed between the student and the EC should clearly mention services being rendered by EC, charges on the same and payment schedule. The Embassy in its previous advisory issued on 18 January, 2024 has mentioned list of authorized agents as received by the universities in Uzbekistan.
- Students should also ensure that they fully comprehend their contract/agreement/acceptance letter issued by the universities. The document should clearly mention the tuition fee which is required to be paid by the student for the entire duration of the course. If the same is not mentioned, the student should seek information from the university on the amount of tuition fee to be paid each year during the course of the study.
- Students must seek itemized breakup of all charges including accommodation, food and other expenses.
- Please note that some newly established institutions particularly private universities may lack infrastructure and laboratory, English speaking faculty and hence not meet NMC’s Foreign Medical Graduate Licentiate (FMGL) regulations 2021.
- Students are also advised to come on student visa to study in Uzbekistan. Few cases of students coming on e-visas have come to Embassy’s attention.
- In case of any difficulty being faced, the Consular Officer of the Embassy may be contacted at cons.tashkent@mea.gov.in
Global e-tender for Import of Urea (46:00:00) on Govt. account (E-tender ID: 2025_NFL_236730_1)
Global e-tender for Import of Urea (46:00:00) on Govt. account (E-tender ID: 2025_NFL_236730_1)
National Fertilizers Limited (NFL) is a Public Sector Undertaking (PSU), a Navratna company under the Department of Fertilizers, Ministry of Chemicals and Fertilizers, Government of India.
NFL has issued the following Global e-tender for importing the following Bulk Fertilizer for the Government Account:
| E-tender No. | Product | Last date of bid submission |
|---|---|---|
| 2025_NFL_236730_1 | Urea (46:00:00) | 12.06.2025 at 14:00 hrs IST |
The advertisement for the same is to be published on 29.05.2025 in:
- English National Daily- Published from Delhi.
- Hindi National Daily- Published from Delhi
The last Date for submission of the tender is detailed in the above table.
The complete tender documents are available on the NFL’s website:- www.nationalfertilizers.com
under the ‘Open Tender’ category and E-tender website:- https://etenders.gov.in/eprocure/app.
For convenience, a complete set of tender documents is attached with the mail. It is requested that the attached documents may please be forwarded to all such reputed manufacturers/traders of Urea as you may deem appropriate, to enable the active participation of major world manufacturers/exporters/traders in our global import e-tender for Urea.
The e-mail id for any correspondence in this regard is imports@nfl.co.in.
IPHEX-2025
iPHEX-2025: India’s Mega Pharma Exhibition & B2B: Inviting Nominations (Importers & Distributors of Pharmaceuticals) for 11th Edition during 04-06th September 2025 at Bharat Mandapam, Delhi, India
iPHEX, an International Exhibition of Pharma and Healthcare organized every year by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) with the support of the Department of Commerce since 2013. iPHEX is an initiative of the Ministry of Commerce to position “India as Pharmacy of the World” and showcase the entire spectrum of the pharmaceuticals and healthcare sector to the world. The exhibition has now become an integral part of the annual business plan of exhibitors and business visitors globally.
The 11th edition of iPHEX will be organized during 04-06th September 2025 at Bharat Mandapam, Delhi, India
Over 700 Indian companies from the Pharma and healthcare sector would be exhibiting their products and services. The exhibition attracts over 20000 domestic visitors as well. The exhibition will be showcasing the products and services of the following segments:
- APIs and Intermediates
- Formulations
- Excipients and Custom Manufacturing
- Bio-similars & Vaccines
- Natural Extracts & Nutraceuticals
- Surgicals
- Animal Health Products
- Healthcare Services (CROs, Clinical Trials, R&D, Custom Synthesis)
Being positioned as a show to promote India’s pharma exports, focused B2B Sessions have been one of the major attractions and one of the most unique feature which sets this exhibition apart in an entirely different league among so many trade shows worldwide.
Business visitors as per the following criteria are invited:
- Top manufacturers of formulations (potential API/raw material importers): 4–5 companies
- Importers of finished drugs/formulations: Reputable importers, existing or potential partners of Indian companies (4–5 companies)
- One official from a government procurement authority
Final invite will be extended as per the business and company profiles/recommendation by the Embassy of India in Tashkent.
It is requested to kindly provide us the following details:
- Details of manufacturing companies in Uzbekistan
- List of importers
- List of chambers/associations
The prospective/invited/recommended business delegate will have to register (mandatory) online for onward processing of applications and final selection process. The link for online registration is
- Hosted Buyer: https://iphex-india.com/hostedbuyer/hosted_buyer_agreement
- Journalist: https://iphex-india.com/journalist/journalist_agreement
- Procurement Agency: https://iphex-india.com/procurementagency/procurementagency_agreement
Last date for online registration: 27 June 2025
For further communication, please write to rbsm@iphex-india.com or call
Mr. Murali Krishna S, Director, at +91-9849283461.
Scholarship for the Academic Session, 2025-26 at Kendriya Hindi Sansthan, Agra (India)
वर्तमान में विदेशी विद्यार्थियों के लिए भारत सरकार की ‘विदेशों में हिंदी प्रचार-प्रसार योजना’ के अंतर्गत चुने गए विदेशी छात्रों के लिए सत्र 2025-26 में केंद्रीय हिंदी संस्थान मुख्यालय, आगरा में निम्नलिखित पाठ्यक्रम आयोजित किए जा रहे हैं –
- हिंदी भाषा दक्षता प्रमाण पत्र – 100
- हिंदी भाषा दक्षता डिप्लोमा – 200
- हिंदी भाषा दक्षता उच्च डिप्लोमा – 300
- हिंदी स्नातकोत्तर डिप्लोमा – 400
मुख्यालय आगरा में प्रवेश प्राप्त करने वाले छात्रों को संस्थान द्वारा प्रत्येक माह रू. 9000/- (INR) मात्र छात्रवृत्ति का भुगतान किया जाता है।
अपने देश से आने एवं जाने (केवल एक बार) का संपूर्ण किराया, जिसमें वायुयान की यात्रा भी शामिल है, का व्यय संस्थान द्वारा वहन किया जाता है।
अंतरराष्ट्रीय शिक्षणपरक पाठ्यक्रमों की अवधि 09 माह (01 अगस्त से 30 अप्रैल तक) के लिए होती है। अध्ययन अवधि में छात्र-छात्राओं के नि:शुल्क आवास हेतु पुरूष एवं महिला छात्रावासों की सुविधाएं उपलब्ध हैं।
आप भी अपने परिचितों एवं विद्यार्थियों को केंद्रीय हिंदी संस्थान, आगरा में पढ़ने का मौका दिला सकते हैं। इसके साथ पाठ्यक्रम से संबंधित पूर्ण विवरण एवं आवेदन पत्र संलग्न है।
संबंधित आवेदन पत्र 31 मई, 2025 तक भारतीय राजदूतावास ताशकंद के माध्यम से ई-मेल (polsec.tashkent@mea.gov.in) से भेजे जा सकते हैं।
The Bilateral Investment Treaty (BIT) between India and Uzbekistan
The Bilateral Investment Treaty (BIT) between India and Uzbekistan
The Bilateral Investment Treaty (BIT) signed between the Government of India and the Government of the Republic of Uzbekistan on 27th September, 2024 in Tashkent has come into effect from 15th May, 2025. The text of the Treaty can be accessed here.
The Treaty promotes investment, protection, transparency, and dispute resolution, and fosters a robust investment environment aimed at enhancing economic cooperation between the two nations.